520 Results

People

  1. Postow
    Postow
  2. Motzer
    Motzer
  3. Wolchok
    Wolchok
  4. Hellmann
    Hellmann
  5. Shoushtari
    Shoushtari
  6. Voss
    Voss
  7. Callahan
    Callahan
  8. Abou-Alfa
    Abou-Alfa
  9. Jones
    Jones
  10. Rosenberg
    Rosenberg

Groups

  1. Department of Medicine (394)
  2. Solid Tumor Oncology Division (337)
  3. Hematologic Malignancies, Division of (108)
  4. Melanoma and Immunotherapeutics Service (108)
  5. Genitourinary Oncology Service (101)
  6. Melanoma Disease Management Team (96)
  7. GSK Faculty (83)
  8. Surgery (71)
  9. Gastrointestinal Oncology Service (65)
  10. Weinberg Fellows (61)
  1. "nivolumab"
Formats
  1. Journal Article (342)
  2. Review (93)
  3. Editorial (41)
  4. Meeting Abstract (18)
  5. Correspondence (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Book Section (4)
  9. Conference Paper (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (394)
  2. Solid Tumor Oncology Division (337)
  3. Hematologic Malignancies, Division of (108)
  4. Melanoma and Immunotherapeutics Service (108)
  5. Genitourinary Oncology Service (101)
  6. Melanoma Disease Management Team (96)

More Groups

People
  1. Michael Postow (55)
  2. Robert Motzer (50)
  3. Jedd Wolchok (41)
  4. Margaret Callahan (28)
  5. Alexander Shoushtari (27)
  6. Matthew Hellmann (26)

More People

Years
  1. 2025 (35)
  2. 2024 (70)
  3. 2023 (75)
  4. 2022 (52)
  5. 2021 (45)
  6. 2020 (64)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (23)
  2. Journal of Clinical Oncology (22)
  3. Journal of Thoracic Oncology (21)
  4. Lancet Oncology (21)
  5. New England Journal of Medicine (19)
  6. Annals of Oncology (17)

More Publications

Publishers
  1. Elsevier Inc. (77)
  2. Elsevier Science, Inc. (50)
  3. Oxford University Press (35)
  4. Wiley Blackwell (32)
  5. Biomed Central Ltd (27)
  6. Nature Publishing Group (27)

More Publishers

Results (520)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)
    Journal Article

    Tawbi, H. A.; Forsyth, P. A.; Hodi, F. S.; Lao, C. D.; Moschos, S. J.; Hamid, O.; Atkins, M. B.; Lewis, K.; Thomas, R. P.; Glaspy, J. A.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Dermatologic infections in cancer patients treated with checkpoint inhibitors
    Journal Article

    Do, M. H.; Barrios, D. M.; Phillips, G. S.; Postow, M. A.; Warner, A. B.; Rosenberg, J. E.; Noor, S. J.; Markova, A.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy?
    Editorial

    Yu, Y.; Zakeri, K.; Lee, N.
    Oncotarget (2021)

    Fulltext@MSK | Save
  • Dynamic biomarkers of response to anti-immune checkpoint inhibitors in cancer
    Editorial

    Dermime, S.; Merhi, M.; Merghoub, T.
    Frontiers in Immunology (2021)

    Fulltext@MSK | Save
  • NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
    Journal Article

    Thielmann, C. M.; Chorti, E.; Matull, J.; Murali, R.; Zaremba, A.; Lodde, G.; Jansen, P.; Richter, L.; Kretz, J.; Möller, I.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Advances in the treatment of gastric cancer: 2020-2021
    Review

    Ilson, D. H.
    Current Opinion in Gastroenterology (2021)

    Fulltext@MSK | Save
  • Advances in pancreatic ductal adenocarcinoma treatment
    Review

    Anderson, E. M.; Thomassian, S.; Gong, J.; Hendifar, A.; Osipov, A.
    Cancers (2021)

    Fulltext@MSK | Save
  • Safety, efficacy, and pharmacodynamics of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma: Randomized expansion of a phase I/II study
    Journal Article

    Kelley, R. K.; Sangro, B.; Harris, W.; Ikeda, M.; Okusaka, T.; Kang, Y. K.; Qin, S.; Tai, D. W. M.; Lim, H. Y.; Yau, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Immunotherapy in esophagogastric cancer
    Review

    Ilson, D. H.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Five-year overall survival from the CheckMate 205 study of nivolumab for relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL)
    Meeting Abstract

    Ansell, S.; Bröckelmann, P.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G.; Cohen, J.; De Boer, J. P.; Kuruvilla, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save